Pages that link to "Q73721296"
Jump to navigation
Jump to search
The following pages link to Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study (Q73721296):
Displaying 50 items.
- Endometriosis: a disease that remains enigmatic (Q21285103) (← links)
- The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life (Q26785614) (← links)
- Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer (Q27009306) (← links)
- Endometriosis and its global research architecture: an in-depth density-equalizing mapping analysis. (Q27308934) (← links)
- The disparate origins of ovarian cancers: pathogenesis and prevention strategies. (Q30240709) (← links)
- The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial-stromal interactions (Q33624201) (← links)
- Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference. (Q33735170) (← links)
- Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials (Q33850475) (← links)
- The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data (Q33956461) (← links)
- Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects (Q34033619) (← links)
- Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis (Q34613189) (← links)
- Staging ovarian cancer: role of imaging (Q34738246) (← links)
- Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development (Q34771886) (← links)
- Inducing malignant transformation of endometriosis in rats by long-term sustaining hyperestrogenemia and type II diabetes (Q35051299) (← links)
- A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation (Q35100056) (← links)
- Endometriosis and ovarian cancer: a systematic review (Q35116887) (← links)
- Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy (Q35545814) (← links)
- Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers (Q35686765) (← links)
- No evidence of endometriosis within serous and mucinous tumors of the ovary (Q35803871) (← links)
- Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma (Q35843312) (← links)
- Endometriosis-associated ovarian cancer: a clinicopathologic review (Q35861595) (← links)
- BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells (Q36017531) (← links)
- Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma (Q36178605) (← links)
- Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma (Q36224971) (← links)
- Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis (Q36358031) (← links)
- Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence (Q36394471) (← links)
- MUC1 in endometriosis and ovarian cancer (Q36751649) (← links)
- Endometriosis-associated ovarian cancer: a review of pathogenesis (Q36790454) (← links)
- The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms (Q36810356) (← links)
- Priorities for endometriosis research: recommendations from an international consensus workshop. (Q36929234) (← links)
- The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study (Q37085824) (← links)
- Prognostic implication of endometriosis in clear cell carcinoma of the ovary (Q37221118) (← links)
- ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas (Q37225222) (← links)
- Malignant Transformation from Endometriosis to Atypical Endometriosis and Finally to Endometrioid Adenocarcinoma within 10 Years (Q37251325) (← links)
- Current understanding of risk factors for ovarian cancer (Q37551696) (← links)
- Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management (Q37621318) (← links)
- The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations (Q37950143) (← links)
- Abdominopelvic washings in gynecologic pathology: A comprehensive review (Q38941768) (← links)
- Analysis of common variations in tumor-suppressor genes on chr1p36 among Caucasian women with endometriosis (Q42664281) (← links)
- An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway (Q43967752) (← links)
- Glypican-3 expression in clear cell adenocarcinoma of the ovary (Q44268931) (← links)
- Prevalence of endometriosis in malignant epithelial ovary tumours (Q44353681) (← links)
- Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. (Q44584852) (← links)
- Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors (Q44611371) (← links)
- Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? (Q45213080) (← links)
- Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis (Q46959757) (← links)
- Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience (Q47741754) (← links)
- Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis (Q47906975) (← links)
- p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer (Q48023151) (← links)
- Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways. (Q53363710) (← links)